BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27601221)

  • 1. Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
    Compton AA; Roy N; Porrot F; Billet A; Casartelli N; Yount JS; Liang C; Schwartz O
    EMBO Rep; 2016 Nov; 17(11):1657-1671. PubMed ID: 27601221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.
    Blyth GA; Chan WF; Webster RG; Magor KE
    J Virol; 2016 Jan; 90(1):103-16. PubMed ID: 26468537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
    Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
    mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1.
    Appourchaux R; Delpeuch M; Zhong L; Burlaud-Gaillard J; Tartour K; Savidis G; Brass A; Etienne L; Roingeard P; Cimarelli A
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
    Shi G; Ozog S; Torbett BE; Compton AA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10069-E10078. PubMed ID: 30301809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay.
    Winkler M; Wrensch F; Bosch P; Knoth M; Schindler M; Gärtner S; Pöhlmann S
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.
    Suddala KC; Lee CC; Meraner P; Marin M; Markosyan RM; Desai TM; Cohen FS; Brass AL; Melikyan GB
    PLoS Pathog; 2019 Jan; 15(1):e1007532. PubMed ID: 30640957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state.
    Rahman K; Coomer CA; Majdoul S; Ding SY; Padilla-Parra S; Compton AA
    Elife; 2020 Oct; 9():. PubMed ID: 33112230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
    Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
    Front Immunol; 2018; 9():228. PubMed ID: 29503647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.
    Hensen L; Matrosovich T; Roth K; Klenk HD; Matrosovich M
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
    Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells.
    Melvin WJ; McMichael TM; Chesarino NM; Hach JC; Yount JS
    Viruses; 2015 Jun; 7(6):3035-52. PubMed ID: 26075508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV.
    Wilkins J; Zheng YM; Yu J; Liang C; Liu SL
    PLoS One; 2016; 11(6):e0156739. PubMed ID: 27257969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry.
    Anafu AA; Bowen CH; Chin CR; Brass AL; Holm GH
    J Biol Chem; 2013 Jun; 288(24):17261-71. PubMed ID: 23649619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity.
    McMichael TM; Zhang L; Chemudupati M; Hach JC; Kenney AD; Hang HC; Yount JS
    J Biol Chem; 2017 Dec; 292(52):21517-21526. PubMed ID: 29079573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.
    Narayana SK; Helbig KJ; McCartney EM; Eyre NS; Bull RA; Eltahla A; Lloyd AR; Beard MR
    J Biol Chem; 2015 Oct; 290(43):25946-59. PubMed ID: 26354436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
    Jia R; Pan Q; Ding S; Rong L; Liu SL; Geng Y; Qiao W; Liang C
    J Virol; 2012 Dec; 86(24):13697-707. PubMed ID: 23055554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.
    Yount JS; Karssemeijer RA; Hang HC
    J Biol Chem; 2012 Jun; 287(23):19631-41. PubMed ID: 22511783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination.
    Chesarino NM; McMichael TM; Hach JC; Yount JS
    J Biol Chem; 2014 Apr; 289(17):11986-11992. PubMed ID: 24627473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.